Start a conversation Capability 08
Generate the evidence that demonstrates value in real clinical practice.
An integrated HEOR and RWE strategy that connects evidence gaps, patient outcomes, payer needs, scientific communication, market access, and lifecycle decisions.
The problem
Clinical trials establish efficacy and safety under defined conditions, but payers, health systems, clinicians, patients, and policy stakeholders often require additional evidence about comparative outcomes, utilization, burden of illness, economic value, treatment patterns, and performance in broader populations.
The HEOS solution
HEOS aligns Medical Affairs, clinical, market access, biostatistics, epidemiology, and commercial stakeholders around a prioritized evidence plan—selecting the right questions, data sources, methods, studies, publications, and decision points for the asset and its lifecycle stage.
How we do it
Senior experts work from assessment through execution, with clear decisions, accountable actions, and measurable outcomes.
Evaluate the target product profile, clinical evidence, stakeholder needs, evidence gaps, value story, access barriers, and lifecycle priorities.
Rank evidence questions by strategic importance, feasibility, timing, stakeholder impact, and decision value.
Select fit-for-purpose methods and data sources, including retrospective or prospective studies, registries, pragmatic research, chart review, claims, EHR, and patient-reported outcomes.
Develop protocols, analysis plans, governance, partners, and execution roadmaps for high-quality HEOR and RWE generation.
Convert results into publications, congress evidence, value communication, payer engagement, medical strategy, and lifecycle decisions.
What you get
How success is measured
The finish line
Experienced expertise. Better decisions.
Tell us what you are evaluating, building, or preparing to execute. We will help you define the right engagement.